| Literature DB >> 31969610 |
Ayşe Kılıç1, Asher Ameli1,2, Jin-Ah Park3, Alvin T Kho4, Kelan Tantisira1, Marc Santolini1,5, Feixiong Cheng6,7,8, Jennifer A Mitchel3, Maureen McGill3, Michael J O'Sullivan3, Margherita De Marzio1,3, Amitabh Sharma1, Scott H Randell9, Jeffrey M Drazen3, Jeffrey J Fredberg3, Scott T Weiss10,11.
Abstract
Bronchospasm compresses the bronchial epithelium, and this compressive stress has been implicated in asthma pathogenesis. However, the molecular mechanisms by which this compressive stress alters pathways relevant to disease are not well understood. Using air-liquid interface cultures of primary human bronchial epithelial cells derived from non-asthmatic donors and asthmatic donors, we applied a compressive stress and then used a network approach to map resulting changes in the molecular interactome. In cells from non-asthmatic donors, compression by itself was sufficient to induce inflammatory, late repair, and fibrotic pathways. Remarkably, this molecular profile of non-asthmatic cells after compression recapitulated the profile of asthmatic cells before compression. Together, these results show that even in the absence of any inflammatory stimulus, mechanical compression alone is sufficient to induce an asthma-like molecular signature.Entities:
Mesh:
Year: 2020 PMID: 31969610 PMCID: PMC6976696 DOI: 10.1038/s41598-020-57755-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Workflow for the analysis of compression induced pathological signatures in HBECs from non-asthmatic donors. HBECs from non-asthmatic donors were compressed and the mRNA expression was detected by RNA-sequencing. Using the human PPI, the compression modules were defined. Pathway enrichment analysis was performed in both, compressed cells and asthmatic HBECs, both normalized to healthy non-asthmatic HBECs.
Figure 2Asthma signature in HBECs. (a) Volcano plot representation of gene expression changes between healthy non-asthmatic and asthmatic HBECs. (b) Pathway enrichment analysis for genes upregulated in the asthmatic HBECs compared to non-asthmatic HBECs. (c) A subnetwork of the asthma disease module is shown. Activated pathways are highlighted in colours. RNA expression of genes promoting inflammation, including the chemokines (d) Ccl2, (e) Cxcl8, sphingosine-1-phosphate receptors (f) S1PR1, (g) S1PR3 as well as the secreted protein (h) TNFSF14. Asthmatic HBECs express elevated remodeling associated factors, including (i) tenascin (TNC), (j) fibronectin 1(FN1), (k) collagen 4 chain Col4a1 and (l) matrix metalloproteinase MMP2. (m) Venn diagram summarizes the gene overlap between the asthma module and publicly available epithelial derived datasets deposited under GSE63142 and GSE37693. Values summarize the expression levels for n = 8 independent samples per group. The box and whisker plots represent the minimum, 25th percentile, median, 75th percentiles and the maximum. *p < 0.05, to control was considered significant.
Active pathways in asthmatic HBECs compared to healthy HBEC at baseline.
| Pathway | adj. p-valuea (Bonferroni) | genes in pathway | |
|---|---|---|---|
| 1 | Integrin cell surface interaction | 4.25E-05 | COL4A2, ICAM1, COL4A1, LAMA1, ITGB6, THBS1, TNC, VCAM1, FN1 |
| 2 | Cytokine- cytokine- receptor interaction | 1.70E-04 | CXCL8, IL1B, CCL2, TNFRSF9, CXCL3, CXCL5, IL6, IFNE, TNFSF14, TNFSF15, CSF1, BMP2, TNFRSF10C, CCL20 |
| 3 | Class A1 Rhodopsin receptor interaction | 4.74E-03 | CCL2, CXCL3, CXCL8, HTR7, S1PR1, AGT, EDNRA, MTNR1A, GPR68, CXCL5, S1PR3, NPBWR1, CCL20 |
| 4 | Platelet amyloid precursor protein pathway | 6.39E-03 | SERPINE1, COL4A2, PLAT, COL4A1 |
| 5 | ECM receptor interaction | 1.18E-02 | COL4A2, FN1, COL4A1, LAMA1, ITGB6, THBS1, TNC |
| 6 | Extracellular matrix organization | 1.49E-02 | COL4A2, COL4A1, MMP2, TLL2, MMP7, MMP17, COL22A1 |
| 7 | local acute inflammatory response pathway | 1.49E-02 | VCAM1, CXCL8, ICAM1, IL6 |
| 8 | Transport of glucose and other sugars, bile, salts, acids, metal ion, and amine compounds | 1.73E-02 | SLC22A3, SLC13A5, SLC39A8, SLC2A3, RHCG, SLC39A2, SLC6A12 |
| 9 | GPCR ligand binding | 2.24E-02 | CCL2, CXCL3, CXCL8, HTR7, S1PR1, AGT, ENDRA, FZD7, MTNR1A, GPR68, CXCL5, S1PR3, NPBWR1, CCL20 |
| 10 | Cartilage oligomeric matrix protein pathway | 3.99E-02 | C1S, C1R, CFB, C4A |
aAdjusted p-value: p-value was calculated using the Fisher exact test and adjustment was done using Bonferroni correction.
Figure 3Compression induced molecular changes in HBECs. (a) Workflow of the methodology used to describe the overlapping and aligning expression signature between healthy HBECs exposed to compression and asthmatic HBECs at baseline. Expression data are collected and then, differentially expressed genes and miRs are mapped to the human interactome, resulting in an early and a late compression disease module. These were compared with the asthma disease module generated in Fig. 1. (b) Volcano plot visualizing DE genes at 3 hr post pressure application and pathways enriched in the early compression module. (c) Volcano plot visualizing DE genes at 24 hr post pressure application (d) and pathways enriched in the late compression module. (e) Visualization of the early (f) and late (g) pressure subnetworks. Activated pathways, overlapping with the asthma subnetwork are highlighted in colour.
Pathways enriched immediately after compressive stress. (3 hr).
| Pathway | adj. p-valuea (Bonferroni) | genes in pathway | |
|---|---|---|---|
| 1 | Hedgehog signalling | 3.55E-07 | RAB23, GLI3, WNT3A, GAS1, BMP7, WNT4, BMP2, WNT10A |
| 2 | Focal adhesion | 4.32E-06 | CAV1, ACTG1, ITGB3, ITGA9, PDGFA, TNC, THBS4, MYL9, VCL, ZYX, JUN, SPP1 |
| 3 | GPCR ligand binding | 1.12E-05 | P2RY1, GPR39, PTGER4, WNT3A, ACKR3, ADM2, ADM, FZD8, WNT4, EDNRA, EDN1, EDN2, WNT10A, FZD2, S1PR5, NPBWR1, S1PR1 |
| 4 | MAPK signalling pathway | 2.46E-05 | DUSP6, DUSP8, DDIT3, CACNA2D2, DUSP5, PDGFA, FOS, SRF, RASA2, JUN, HSPA6, FGF1, DUSP9 |
aAdjusted p-value: p-value was calculated using the Fisher exact test and adjustment was done using Bonferroni correction.
Gene ontology analysis of genes immediately induced after compression.
| Term | adj. p-valuea | Genes |
|---|---|---|
| Focal Adhesion (GO:0005925) | 9.15E-10 | DST, TPM4, FBLIM1, ITGB3, TGFB1I1, FHL1, SPRY4, FHL2, PLAUR, TNC, MSN, RHOB, CSRP1, PALLD, DLC1, MYH9, LCP1, FERMT2, PDLIM7, VCL |
| Cytoskeleton (GO:0005856) | 2.23E-04 | DST, TPM4, MSN, NUAK1, KRT17, PALLD, CDC42EP2, MYH9, SPRY2, STK38L, LCP1, PDLIM5, NES, ULBP1, PDLIM7, VCL |
| Actin Cytoskeleton (GO:0015629) | 4.40 E-3 | TPM4, PALLD, DLC1, MYADM, MYH9, STK38L, LCP1, PDLIM5, ULBP1, PDLIM7 |
| Contractile Actin Filament bundle (GO:0097517) | 6.15 E-03 | TPM4, FBLIM1, MYH9, LCP1 |
| Stress Fibre (GO:0001725) | 6.15 E-03 | TPM4, FBLIM1, MYH9, LCP1 |
| Actomyosin (GO:0042641) | 1.02 E-02 | TPM4, FBLIM1, MYH9, LCP1 |
aAdjusted p-value: p-value was calculated using the Fisher exact test and adjustment was done using Bonferroni correction.
Figure 4Compression induced remodeling associated genes. Genes, related to fibrotic responses, are elevated at 24 hr post compression. This list includes the soluble factors (a) platelet-derived growth factor β (PDGFB) and (b) transforming growth factor-β2 (TGFB2). As downstream targets of the fibrotic response we highlight (c) Col1a1, (d) Col4a1, (e) matrix metalloproteinases MMP-2 and (f) MMP-10. Values summarize the expression levels for n = 8 independent samples per group. The box and whisker plots represent the minimum, 25th percentile, median, 75th percentiles and the maximum. *p < 0.05 compared to control was considered significant.
Pathways enriched after compressive stress. (24 h).
| Pathway | adj. p-valuea | genes in pathway | |
|---|---|---|---|
| 1 | Extracellular matrix organization | 6.03E-11 | COL4A3, COL4A2, COL16A1, MMP3, COL4A1, MMP11, MMP13, COL4A4, COL1A1, MMP2, MMP10, COL5A2, COL8A2, COL7A1 |
| 2 | Focal adhesion | 2.30E-09 | COL4A2, CAV1, COMP, COL4A1, ITGB3, ITGB6, ITGA9, PDGFB, THBS1, TNC, COL1A1, COL4A4, PDGFD, MYL9, JUN, COL5A2, ITGA4, ACTN1 |
| 3 | ECM receptor interaction | 5.84E-09 | COL4A2, COL4A4, COMP, COL4A1, ITGB3, ITGA9, ITGB6, THBS1, TNC, COL1A1, COL5A2, ITGA4, |
| 4 | Integrin cell surface interaction | 3.53E-07 | COL4A3, COL4A2, COL4A4, COL4A1, ITGB3, ITGA9, ITGB6, THBS1, TNC, COL1A1 |
| 5 | TGFbeta pathway | 7.88E-07 | SMAD7, LTBP1, COMP, THBS1, INHBA, BMP6, BMP7, TGFB2, CDKN2B, FST |
| 6 | Cytokine- cytokine- receptor interaction | 9.01E-07 | CXCL8, CXCR2, KIT, TNFSF13B, IL11, INHBA, TNFSF9, PDGFB, IL6R, TNFSF14, CXCR4, CXCL14, BMP7, LIF, TGFB2, NGFR, GHR |
| 7 | PDGF pathway | 1.88E-05 | COL4A3, COL4A2, COL4A4, COL4A1, PDGFB, THBS1, COL1A1, PDGFD, COL5A2, CAMK4, |
| 8 | Kinesins | 2.72E-05 | KIF4A, KIF15, KIF2C, KIF11, KIFC1 |
aAdjusted p-value: p-value was calculated using the Fisher exact test and adjustment was done using Bonferroni correction.
Figure 5Compression induced alarmins and Th2-promoting mediators in healthy non-asthmatic HBECs. Compression on HBECs immediately (3 hr) induced the expression of (a) IL33, (b) Th2-promoting thymic stromal lymphopoietic protein (TSLP) as well as Cxcl8 (c). This response was accompanied by immediate increase in lipid-mediator receptors (d) S1PR1 and (e) Prostaglandin E Receptor 4 (PTGER4). Values summarize the expression levels for n = 8 independent samples per group. The box and whisker plots represent the minimum, 25th percentile, median, 75th percentiles and the maximum. *p < 0.05 compared to control was considered significant.